The MHRA will implement a 14-day assessment process for phase I trials to expedite early new medicine testing. Credit: Wasan...
Regulatory
Supervisory priorities continue to evolve. This quarter, the ECB updated its 2024-2026 priorities (see more in the deep dive article below) and...
